cholesterol guidelines recently introduced can significantly reduce new cardiovascular events, compared with guidelines based on previous cholesterol treatment, a study they found conducted by researchers at UT Southwestern.
New guidelines for reducing cholesterol strokes and heart attacks
The research identified participants Dallas Heart Study in the age range of 30 and 65 who have recently qualified for statin use under the new cholesterol guidelines introduced in 2013 by the American College of Cardiology (ACC) and the American Association Heart (AHA).
In this subgroup of patients, the study predicted that would have been prevented from 3.6 to 4.9 cardiovascular events per 1,000 persons examined and treated in accordance with the new guidelines instead of the old guidelines (with a reduction factor risk 30 percent to 45 percent, depending on the dose of statins). The Dallas Heart Study is a multiethnic study, based on thousands of adult population of Dallas County, whose cardiovascular health has been followed for 10 years.
The projection of these findings on the Dallas County largest population, about 4,500 have been avoided serious heart problems in individuals 30 to 65 years of age over a period of 10 years following the new cholesterol guidelines.
When the new guidelines were introduced – replacing previous guidelines Education Program / Third Adult Treatment Panel of the National Cholesterol – provoked a heated debate about the considerable increase in statin eligibility. However, the UT? Southwest study supports the merit of the new cholesterol guidelines as well as increased use of statins.
? “This is one of the first studies to carefully predict the implications of the new guidelines for the general population beyond the amount of increased use of statins,” Dr. Amit Khera said, Associate Professor of Internal Medicine and Director of preventive cardiology program at UT? Southwest. “It seems that these new guidelines will prevent heart attacks and strokes? The answer is ‘yes’,” he said.
Khera is the lead author of the recently published study, which appeared in Circulation :. Cardiovascular Quality and Outcomes
Guidelines Cholesterol / AHA 2013 ACC recommend statins for patients with existing cardiovascular atherosclerotic disease, type 2 diabetes, and high levels of LDL cholesterol, as well as for patients with a high risk of 10 years for heart disease.
The above guidelines of the National Cholesterol / Third Adult Treatment Panel Education Program are based on a different formula that involved targeting specific cholesterol levels. Some patients are left out of statin eligibility under the new guidelines, but some are more than 12.8 million newly eligible.
Among the Dallas Heart Study participants who actually experienced a cardiovascular event, 37.1 percent of these patients have been placed on statins if the new guidelines had been in place. Among participants who did not experience a cardiovascular event, only 3.9 percent of patients had been prescribed statins.
“There has been a lot of emphasis on increasing the use of statins and much emphasis on risk calculator” said Dr. Khera, who holds the chair of the Dallas Heart Ball in hypertension and heart disease. “Yes, there is some additional use statin, but according to our results, this use seems appropriate, at least in this age group.”
This article was originally published on medindia.net
Posted in: health news